SPOTLIGHT -
Up to 50% of cases of cannabis-induced psychosis covert to schizophrenia. A new study provides striking evidence for abuse of other substances and schizophrenia onset.
Innovations in Clinical Research
Treating ‘Morally Objectionable’ Patients
Presenting Our July Theme: Schizophrenia
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Clinical Trials of Prescription Digital Therapeutics for Schizophrenia
Questions and Answers About Clozapine: A Dialogue About the Use of Plasma Levels